Annexon Biosciences

United States · 82 Employees
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company's pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.

概述

国家 United States
成立时间 2011
总部 180 Kimball Way, Suite 200, South San Francisco, California 94080, US
电话号码 +1 650-822-5500
网站 http://www.annexonbio.com
LinkedIn http://www.linkedin.com/company/annexon-biosciences
Twitter https://twitter.com/annexonbio
Facebook
员工数 82
行业 research,
简介 Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company's pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.

技术

Adobe Marketing Cloud

Search Marketing

Bootstrap Framework

CSS and JavaScript Libraries

Google Cloud Hosting

Hosting

Google Tag Manager

Tag Management

Microsoft Office 365

Other

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Nginx

Load Balancers

Outlook

Email Providers

WP Engine

CMS

WordPress.org

CMS

常见问题

Annexon Biosciences 在哪里?

Annexon Biosciences 的总部位于 180 Kimball Way, Suite 200, South San Francisco, California 94080, US

Annexon Biosciences 的电话号码是多少?

Annexon Biosciences 的电话号码是 +1 650-822-5500

Annexon Biosciences 的官方网站是什么?

Annexon Biosciences 的公司官方网站是 http://www.annexonbio.com

Annexon Biosciences 是做什么的?

Annexon Biosciences 的业务有哪些?

autoimmune,neurodegeneration,ophthalmology

Annexon Biosciences 的年收入是多少?

Annexon Biosciences 的收入是 0美元

Annexon Biosciences 有多少员工?

Annexon Biosciences 有 82 名员工

Annexon Biosciences 属于哪个行业?

Annexon Biosciences 从事以下行业: research

Annexon Biosciences 使用什么技术?

Annexon Biosciences 使用的一些流行技术包括: Adobe Marketing Cloud,Bootstrap Framework,Google Cloud Hosting,Google Tag Manager,Microsoft Office 365,Mobile Friendly,New Relic,Nginx,Outlook,WP Engine,WordPress.org

如何联系 Annexon Biosciences?

Annexon Biosciences 联系信息: 电话号码:+1 650-822-5500, 网站:http://www.annexonbio.com, 邮箱:dfo***@***.com

Annexon Biosciences 的社交媒体链接是什么?

Annexon Biosciences 领英:http://www.linkedin.com/company/annexon-biosciences,fackbook:,twitte:https://twitter.com/annexonbio

Annexon Biosciences 是一家上市公司吗?

是的,Annexon Biosciences是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:ANNX

Annexon Biosciences 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Annexon Biosciences?

Annexon Biosciences 有 0 家投资者,包括 。

管理层

Donald Fong

VP, Head of Ophthalmology

Harman Hansra

Sr. Director, Global Clinical Ops

Annalisa McLafferty

Sr. Clinical Trial Manager

Holly Lin

Director, Biomarker Operations

员工

Asina

Division Counsel

Uni Buckley

Sr. Executive Assistant

William W

Board Member, Audit Chair

Spencer Wu

Bioanalytical Scientist

Michael O

Executive Vice President and Chief Business Officer

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google